Efficacy of Curcuma longa extract in an in vivo model of Rhizopus oryzae infection in neutropenic mice
Abstract
Mucormycosis, a life-threatening fungal infection caused by Rhizopus oryzae, disproportionately affects immunosuppressed individuals. Current treatments face significant limitations, necessitating alternative approaches. This study investigates the therapeutic potential of ethanolic extracts of Curcuma longa (C. longa), known for its antifungal and immunomodulatory properties, in a neutropenic mouse model of mucormycosis. Mice were infected with R. oryzae and treated with C. longa extracts at 100, 200 and 400 mg/kg doses. Key parameters assessed included survival rates, body weight, hematological profiles (RBC, HGB, PLT), organ weights, fungal burden in kidney and brain tissues, and immunological responses. The 400 mg/kg dose significantly improved survival rates, hematological recovery, and normalized organ weights, with reductions in fungal burden comparable to standard treatment. Mice also exhibited dose-dependent recovery in systemic health. However, incomplete recovery and some mortalities were noted, highlighting the need for further optimization. These findings suggest C. longa extracts possess antifungal, immunomodulatory, and systemic protective effects, offering a promising natural alternative for mucormycosis management in immunosuppressed hosts. Future research should focus on refining dosing strategies and establishing clinical safety and efficacy profiles.
Keywords:
Curcuma longa, In-Vivo Animal Study, Anti-Fungal Activity , Ethanolic ExtractsDOI
https://doi.org/10.25004/IJPSDR.2025.170207References
Fahira A, Soraya A, Achmadsyah AR, Hakim RW. Efficacy and safety of Curcuma longa extract in the treatment of osteoarthritis: a systematic review. Int J Appl Pharm. 2019 Nov;11:140-5. Available from: doi.org/10.22159/ijap.2019.v11s6.33578
Zeng L, Yu G, Hao W, Yang K, Chen H. The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis. Bioscience reports. 2021 Jun;41(6):BSR20210817. Available from: doi.org/10.1042/BSR20210817
Wang ZQ, Jones G, Winzenberg T, Guoqi Cai M, Laslett LL, Aitken D, Hopper I, Singh A, Jones R, Fripp J, Ding CH. Effectiveness of Curcuma longa extract for the treatment of symptoms and effusion-synovtis of knee osteoarthritis. Annals of Internal Medicine. 2020; 173: 861-9. Available from: doi.org/10.7326/M20-0990.
Mesa MD, Ramírez Tortosa MC, Aguilera García CM, Ramírez-Boscá A, Gil Hernández Á. Efectos farmacológicos y nutricionales de los extractos de Curcuma longa L. y de los cucuminoides. Ars Pharm. 2000; 41(1): 307-21. Available from: doi.org/10.30827/ARS.V41I1.5741
Lewis RE, Leventakos K, Liao G, Kontoyiannis DP. Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis. Antimicrobial Agents and Chemotherapy. 2011; 55: 3584-7. Available from: doi.org/10.1128/AAC.01812-10
Ibrahim AS, Bowman JC, Avanessian V, Brown K, Spellberg B, Edwards Jr JE, Douglas CM. Caspofungin inhibits Rhizopus oryzae 1, 3-β-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrobial Agents and Chemotherapy. 2005; 49: 721-7. Available from: doi.org/10.1128/AAC.49.2.721-727.2005
Ibrahim AS, Avanessian V, Spellberg B, Edwards Jr JE. Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrobial Agents and Chemotherapy. 2003; 47: 3343-4. Available from: doi.org/10.1128/AAC.47.10.3343-3344.2003
Dos Santos AR, Fraga-Silva TF, Almeida DD, Dos Santos RF, Finato AC, Amorim BC et al. Rhizopus-host interplay of disseminated mucormycosis in immunocompetent mice. Future microbiology. 2020; 15(9): 739-52. Available from: doi.org/10.2217/fmb-2019-0246
Cho JY, Choi GJ, Lee SW, Lim HK, Jang KS, Lim CH et al. In vivo antifungal activity against various plant pathogenic fungi of curcuminoids isolated from the rhizomes of Curcuma longa. Plant Pathology Journal. 2006; 22: 94-6. Available from: doi.org/10.5423/PPJ.2006.22.1.094
Kim MK, Choi GJ, Lee HS. Fungicidal property of Curcuma longa L. rhizome-derived curcumin against phytopathogenic fungi in a greenhouse. Journal of agricultural and food chemistry. 2003; 51(6): 1578-81. Available from: doi.org/10.1021/JF0210369
Anh, Phương et al. Growth Inhibitory Activities of the Rhizome Crude Extract of Curcuma longa on the Human Pathogenic Fungus Mucor Circinelloides. Journal of Science, Natural Science. 2020; 65: 82-91 (2020). Available from: doi.org/10.18173/2354-1059.2020-0051
Araujo CA, Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz, Rio de Janeiro, 2001; 96(5): 723-8. Available from: doi.org/10.1590/S0074-02762001000500026
Shoham S, Magill SS, Merz WG, Gonzalez C, Seibel N, Buchanan WL, Knudsen TA, Sarkisova TA, Walsh TJ. Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases. Medical mycology. 2010 May 1;48(3):511-7. Available from: doi.org/10.3109/13693780903311944
Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW et al. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. The Journal of clinical investigation. 2007; 117(9): 2649–57. Available from: doi.org/10.1172/JCI32338
Chourasiya P, Gour R, Patel AK. Qualitative Phytochemical Investigation and Acute Oral Toxicity Study on Ethanolic Extract of Curcuma longa Leaves. Journal of Drug Delivery and Therapeutics. 2024;14(1):73–8. Available from: 10.22270/jddt.v14i1.6244
Lee HB, Lee YR, Yoo G, Yim S, Son HK, Kang CG et al. Curcuma longa rhizome extract activates brown adipocytes and inhibits lipogenesis in high-fat diet-fed mice. Journal of Functional Foods. 2024;122:106490. Available from: doi.org/10.1016/j.jff.2024.106490.
Lee YS, Kim KW, Jin BR, Lee DS, Ko W, Kim HM, et al. The ethanolic extract of Korean Curcuma longa rhizome inhibits adipogenesis in 3T3-L1 adipocytes and high-fat diet-induced obese mice via activating AMPK signaling pathway. Journal of Functional Foods. 2023; 110: 105854. Available from: doi.org/10.1016/j.jff.2023.105854
Rodríguez MM, Pastor FJ, Sutton DA, Calvo E, Fothergill AW, Salas V, et al. Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice. Antimicrobial Agents and Chemotherapy. 2010; 54(5): 1665–9. Available from: doi.org/10.1128/AAC.01463-09
Published
Abstract Display: 62 
PDF Downloads: 62 How to Cite
Issue
Section
Copyright (c) 2025 Mr. Amar P. Patil
This work is licensed under a Creative Commons Attribution 4.0 International License.
